Telavancin is a novel semisynthetic lipoglycopeptide derivative of vancomycin with a dual mode of action. This study sought to understand the mechanisms of decreased telavancin susceptibility in a laboratory-derived Staphlococcus aureus mutant TlvDSMED1952. There were extensive changes in the transcriptome of TlvDSMED1952 compared to the susceptible parent strain MED1951. Genes upregulated included cofactor biosynthesis genes, cell wall-related genes, fatty acid biosynthesis genes, and stress genes. Downregulated genes included lysine operon biosynthesis genes and lrgB, which are induced by telavancin in susceptible strains, agr and kdpDE genes, various cell surface protein genes, phenol-soluble modulin genes, several protease genes, and genes involved in anaerobic metabolism. The decreased susceptibility mutant had somewhat thicker cell walls and a decreased autolytic activity that may be related to decreased proteolytic peptidoglycan hydrolase processing. Membrane fatty acid changes correlated with increased membrane fluidity were observed. It seems likely that there are multiple genetic changes associated with the development of decreased telavancin susceptibility. The TlvDS mutant showed some similar features to vancomycin-intermediate S. aureus and decreased daptomycin susceptibility strains, but also exhibited its own unique features.
Get full access to this article
View all access options for this article.
References
1.
BayerA.S., PrasadR., ChandraJ., KoulA., SmritiM., VarmaA., SkurrayR.A., FirthN., BrownM.H., KooS.P., YeamanM.R.2000. In vitro resistance of Staphylococcus aureus to thrombin-induced platelet microbicidal protein is associated with alterations in cytoplasmic membrane fluidity. Infect. Immun., 68:3548–3553.
2.
ChambersH.F., DeleoF.R.2009. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat. Rev. Microbiol., 7:629–641.
3.
ClarkeS.R.2010. Phenol-soluble modulins of Staphlococcus aureus lure neutrophils into battle. Cell Host Microbe., 7:423–424.
4.
DelauneA., PoupelO., MalletA., CoicY.-M., MsadekT., DubracS.2011. Peptidoglycan crosslinking relaxation plays an important role in Staphylococcus aureus WalKR-dependent cell viability. Plos One, 6:e17054.
5.
DraghiD.C., BentonB.M., KrauseK.M., ThornsberryC., PillarC., SahmD.F.2008. Comparative surveillance study of telavancin activity against recently collected gram-positive clinical isolates from across the United States. Antimicrob. Agents Chemother., 52:2383–2388.
6.
DubracS., BonecaI.G., PoupelO., MsadekT.2007. New insights into the WalK/WalR (YycG/YycF) essential signal transduction pathway reveal a major role in controlling cell wall metabolism and biofilm formation in Staphylococcus aureus. J. Bacteriol., 189:8257–8269.
7.
GardeteS., KimC., HartmannB.M., MwangiM., RouxC.M., DunmanP.M., ChambersH.F., TomaszA.2012. Genetic pathway in acquisition and loss of vancomycin resistance in a methicillin-resistant Staphylococcus aureus (MRSA) strain of clonal type USA300. Plos Pathogens, 8:e1002505.
Hanawa-SuetsuguK., TakagiM., InokuchiH., HimenoH., MutoA.2002. SmpB functions in various steps of trans-translation. Nucleic Acids Res., 30:1620–1629.
10.
HegdeS.S., ReyesN., SkinnerR., DifuntorumS.2008. Efficacy of telavancin in a murine model of pneumonia induced by methicillin-susceptible Staphylococcus aureus. J. Antimicrob. Chemother., 61:169–172.
11.
HigginsD.L., ChangR., DebabovD.V., LeungJ., WuT., KrauseK.M., SandvikE., HubbardJ.M., KanigaK., SchmidtD.E.Jr., GaoQ., CassR.T., KarrD.E., BentonB.M., HumphreyP.P.2005. Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother., 49:1127–1134.
12.
HowdenB.P., DaviesJ.K., JohnsonP.D., StinearT.P., GraysonM.L.2010. Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanism, laboratory detection, and clinical implications. Clin. Microbiol. Rev., 23:99–139.
13.
JohnsonJ.K., HarrisA.D., ShardellM.D., McGregorJ.C., ThomK.A., PerencevichE.N.2011. Increased mortality with accessory gene regulator (agr) dysfunction in Staphylococcus aureus among bacteremic patients. Antimicrob. Agents Chemother., 55:1082–1087.
14.
KaenjakA., GrahamJ.E., WilkinsonB.J.1993. Choline transport activity in Staphylococcus aureus induced by osmotic stress and low phosphate concentrations. J. Bacteriol., 175:2400–2406.
15.
KlevensR.M., MorrisonM.A., NadleJ., PetitS., GershmanK., RayS., HarrisonL.H., LynfieldR., DumyatiG., TownesJ.M., CraigA.S., ZellE.R., FosheimG.E., McDougalL.K., CareyR.B., FridkinS.K.2007. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA, 298:1763–1771.
16.
KoehlJ.L., MuthaiyanA., JayaswalR.K., EhlertK., LabischinskiH., WilkinsonB.J.2004. Cell wall composition and decreased autolytic activity and lysostaphin susceptibility of glycopeptide-intermediate Staphylococcus aureus. Antimicrob. Agents Chemother., 48:3749–3757.
17.
Kosowska-ShickK., ClarkC., PankuchG.A., McGheeP., DewasseB., BeachelL., AppelbaumP.C.2009. Activity of telavancin against staphylococci and enterococci determined by MIC and resistance selection studies. Antimicrob. Agents Chemother., 53:4217–4224.
18.
Lamichhane-KhadkaR., RiordanJ.T., DelgadoA., MuthaiyanA., ReynoldsT.D., WilkinsonB.J., GustafsonJ.E.2008. Genetic changes that correlate with the pine-oil disinfectant-reduced susceptibility mechanism of Staphylococcus aureus. J. Appl. Microbiol., 105:1973–1981.
LedalaN., WilkinsonB. J., JayaswalR. K.2006. Effect of oxacillin and tetracycline on autolysis, autolysis processing and atl transcription in Staphylococcus aureus. Int. J. Antimicrob. Agents, 27:518–524.
21.
LiM., ChaD.J., LaiY., VillaruzA.E., SturdevantD.E., OttoM.2007. The antimicrobial peptide-sensing system aps of Staphylococcus aureus. Mol. Microbiol., 66:1136–1147.
22.
LiuG.Y., EssexA., BuchananJ.T., DattaV., HoffmanH.M., BastianJ.F., FiererJ., NizetV.2005. Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity. J. Exp. Med., 202:209–215.
23.
LundeC.S., HartouniS.R., JancJ.W., MammenM., HumphreyP.P., BentonB.M.2009. Telavancin disrupts the functional integrity of the bacterial membrane through targeted interaction with the cell wall precursor lipid II. Antimicrob. Agents Chemother., 53:3375–3383.
MishraN.N., McKinnellJ., YeamanM.R., RubioA., NastC.C., ChenL., KreiswirthB.N., BayerA.S.2011. In vitro cross-resistance of daptomycin and host defense cationic antimicrobial peptides in clinical methicillin-resistant Staphylococcus aureus (MRSA) isolates. Antimicrob. Agents Chemother., 55:4012–4018.
26.
MuthaiyanA., SilvermanJ.A., JayaswalR.K., WilkinsonB.J.2008. Transcriptional profiling reveals that daptomycin induces the Staphylococcus aureus cell wall stress stimulon and genes responsive to membrane depolarization. Antimicrob. Agents Chemother, 52:980–990.
27.
NielsenL.E., KadavyD.R., RajagopalS., DrijberR., NickersonK.W.2005. Survey of extreme solvent tolerance in gram-positive cocci: membrane fatty acid changes in Staphylococcus haemolyticus grown in toluene. Appl. Environ. Microbiol., 71:5171–5176.
28.
NovickR.P., GeisingerE.2008. Quorum sensing in staphylococci. Annu. Rev. Genet., 42:541–564.
29.
PfeltzR.F., WilkinsonB.J.2004. The escalating challenge of vancomycin resistance in Staphylococcus aureus. Curr. Drug Targets Infect Disord., 4:273–294.
30.
QoronflehM.W., WilkinsonB.J.1986. Effects of growth of methicillin-resistant and -susceptible Staphylococcus aureus in the presence of β-lactams on peptidoglycan structure and susceptibility to lytic enzymes. Antimicrob. Agents Chemother., 29:250–257.
31.
RecordM.T.Jr., CourtenayE.S., CayleyD.S., GuttmanH.J.1998. Responses of E. coli to osmotic stress: large changes in amounts of cytoplasmic solutes and water. Trends Biochem. Sci., 23:143–148.
32.
ReyesD., AndreyD.O., MonodA., KelleyW.L., ZhangG., CheungA.L.2011. Coordinated regulation by AgrA, SarA and SarB and SarR to control agr expression in Staphyloccus aureus. J. Bacteriol., 193:6020–6031.
33.
Saïd-SalimB., DunmanP.M., McAleeseF.M., MacapagalD., MurphyE., McNamaraP.J., ArvidsonS., FosterT.J., ProjanS.J., KreiswirthB.N.2003. Global regulation of Staphylococcus aureus genes by rot. J. Bacteriol., 185:2610–2619.
34.
SchweizerM.L., FurunoJ.P., SakoulasG., JohnsonJ.K., HarrisA.D., ShardellM.D., McGregorJ.C., ThomK.A., PerencevichE.N.2011. Increased mortality with accessory gene regulator (agr) dysfunction in Staphylococcus aureus among bacteremic patients. Antimicrob Agents Chemother., 55:1082–1087
35.
ShawL.N., GolonkaE., SzmydG., FosterS.J., TravisJ., PotempaJ.2005. Cytoplasmic control of premature activation of a secreted protease zymogen: deletion of staphostatin B (SspC) in Staphylococcus aureus 8325–4 yields a profound pleiotropic phenotype. J. Bacteriol., 187:1751–1762.
36.
ShimizuY, UedaT.2002. The role of SmpB protein in trans-translation. FEBS Lett., 514:74–77.
37.
ShojiM., CuiL., IizukaR., KomotoA., NeohH.M., WatanabeY., HishinumaT., HiramatsuK.2011. The walK and clpP mutations confer reduced vancomycin susceptibility on Staphylococcus aureus. Antimicrob. Agents Chemother., 55:3870–3081.
38.
SinghV.K., HattangadyD.S., GiotisE.S., SinghA.K., ChamberlainN.R., StuartM.K., WilkinsonB.J.2008. Insertional inactivation of branched chain α-keto acid dehydrogenase in Staphylococcus aureus leads to decreased branched-chain membrane fatty acid content and increased susceptibility to certain stresses. Appl. Environ. Microbiol., 74:5882–5890.
39.
SongY., LundeC.S., BentonB.M., WilkinsonB.J.2012. Further insights into the mode of action of the lipoglycopeptide telavancin through global gene expression studies. Antimicrob. Agents Chemother., 56:3157–3164.
40.
StapletonM.R., HorsburghM.J., HayhurstE.J., WrightL., JonssonI.-M., TarkowskiA., Kokai-KunJ.F., MondJ.J., FosterS.J.2007. Characterization of IsaA and SceD, two putative lytic transglycosylases of Staphylococcus aureus. J. Bacteriol., 189:7316–7325.
41.
TannakeY., MorikawaK., OhkiY., YaoM., TsumotK., WatanabeN., OhtaT., TanakaI.2007. Structural and mutational analyses of Drp35 from Staphylococcus aureus. J. Biol. Chem., 282:5770–5780.
42.
TownsendD.E., KaenjakA., JayaswalR.K., WilkinsonB.J.2006. Proline is biosynthesized from arginine in Staphylococcus aureus. Microbiology., 142:1491–1497.
43.
TsujiB.T., RybakM.J., LauK.L., SakoulasG.2007. Evaluation of accessory gene regulator (agr) group and function in the proclivity towards vancomycin intermediate resistance in Staphylococcus aureus. Antimicrob. Agents Chemother., 51:1089–1091.
44.
UtaidaS., DunmanP.M., MacapagalD., MurphyE., ProjanS.J., SinghV.K., JayaswalR.K., WilkinsonB.J.2003. Genome-wide transcriptional profiling of the response of Staphylococcus aureus to cell-wall-active antibiotics reveals a cell-wall-stress stimulon. Microbiology, 149:2719–2732.
45.
VijaranakulU., NadakavukarenM.J., de JongeB.L., WilkinsonB.J., JayaswalR.K.1995. Increased cell size and shortened peptidoglycan interpeptide bridge of NaCl-stressed Staphylococcus aureus and their reversal by glycine betaine. J. Bacteriol., 177:5116–5121.
46.
WilkinsonB.J., MuthaiyanA., JayaswalR.K.2005. The cell wall stress stimulon of Staphylococcus aureus and other gram-positive bacteria. Curr. Med. Chem. Anti-Infective Agents., 4:259–276.
47.
XueT., YouY., HongD., SunH., SunB.2011. The Staphylococcus aureus KdpDE two-component system couples extracellular K+ sensing and Agr signaling to infection programming. Infect Immun., 79:2154–2167.
48.
YangS.J., XiongY.Q., Boyle-VavraS., DaumR., JonesT., BayerA.S.2010. Daptomycin-oxacillin combinations in treatment of experimental endocarditis caused by daptomycin-nonsusceptible strains of methicillin-resistant Staphylococcus aureus with evolving oxacillin susceptibility (the “seesaw effect”.)Antimicrob. Agents Chemother, 54:3161–3169.
ZhuK., BaylesD.O., XiongA., JayaswalR.K., WilkinsonB.J.2005. Precursor and temperature modulation of fatty acid composition and growth of Listeria monocytogenes cold-sensitive mutants with transposon-interrupted branched-chain α-keto acid dehydrogenase. Microbiology, 151:615–623.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
